Performance and Robustness of the Monte Carlo Importance Sampling Algorithm Using Parallelized S-ADAPT for Basic and Complex Mechanistic Models
The Monte Carlo Parametric Expectation Maximization (MC-PEM) algorithm can approximate the true log-likelihood as precisely as needed and is efficiently parallelizable. Our objectives were to evaluate an importance sampling version of the MC-PEM algorithm for mechanistic models and to qualify the de...
        Saved in:
      
    
          | Published in | The AAPS journal Vol. 13; no. 2; pp. 212 - 226 | 
|---|---|
| Main Authors | , | 
| Format | Journal Article | 
| Language | English | 
| Published | 
        Boston
          Springer US
    
        01.06.2011
     | 
| Subjects | |
| Online Access | Get full text | 
| ISSN | 1550-7416 1550-7416  | 
| DOI | 10.1208/s12248-011-9258-9 | 
Cover
| Abstract | The Monte Carlo Parametric Expectation Maximization (MC-PEM) algorithm can approximate the true log-likelihood as precisely as needed and is efficiently parallelizable. Our objectives were to evaluate an importance sampling version of the MC-PEM algorithm for mechanistic models and to qualify the default estimation settings in SADAPT-TRAN. We assessed bias, imprecision and robustness of this algorithm in S-ADAPT for mechanistic models with up to 45 simultaneously estimated structural parameters, 14 differential equations, and 10 dependent variables (one drug concentration and nine pharmacodynamic effects). Simpler models comprising 15 parameters were estimated using three of the ten dependent variables. We set initial estimates to 0.1 or 10 times the true value and evaluated 30 bootstrap replicates with frequent or sparse sampling. Datasets comprised three dose levels with 16 subjects each. For simultaneous estimation of the full model, the ratio of estimated to true values for structural model parameters (median [5–95% percentile] over 45 parameters) was 1.01 [0.94–1.13] for means and 0.99 [0.68–1.39] for between-subject variances for frequent sampling and 1.02 [0.81–1.47] for means and 1.02 [0.47–2.56] for variances for sparse sampling. Imprecision was ≤25% for 43 of 45 means for frequent sampling. Bias and imprecision was well comparable for the full and simpler models. Parallelized estimation was 23-fold (6.9-fold) faster using 48 threads (eight threads) relative to one thread. The MC-PEM algorithm was robust and provided unbiased and adequately precise means and variances during simultaneous estimation of complex, mechanistic models in a 45 dimensional parameter space with rich or sparse data using poor initial estimates. | 
    
|---|---|
| AbstractList | The Monte Carlo Parametric Expectation Maximization (MC-PEM) algorithm can approximate the true log-likelihood as precisely as needed and is efficiently parallelizable. Our objectives were to evaluate an importance sampling version of the MC-PEM algorithm for mechanistic models and to qualify the default estimation settings in SADAPT-TRAN. We assessed bias, imprecision and robustness of this algorithm in S-ADAPT for mechanistic models with up to 45 simultaneously estimated structural parameters, 14 differential equations, and 10 dependent variables (one drug concentration and nine pharmacodynamic effects). Simpler models comprising 15 parameters were estimated using three of the ten dependent variables. We set initial estimates to 0.1 or 10 times the true value and evaluated 30 bootstrap replicates with frequent or sparse sampling. Datasets comprised three dose levels with 16 subjects each. For simultaneous estimation of the full model, the ratio of estimated to true values for structural model parameters (median [5-95% percentile] over 45 parameters) was 1.01 [0.94-1.13] for means and 0.99 [0.68-1.39] for between-subject variances for frequent sampling and 1.02 [0.81-1.47] for means and 1.02 [0.47-2.56] for variances for sparse sampling. Imprecision was ≤25% for 43 of 45 means for frequent sampling. Bias and imprecision was well comparable for the full and simpler models. Parallelized estimation was 23-fold (6.9-fold) faster using 48 threads (eight threads) relative to one thread. The MC-PEM algorithm was robust and provided unbiased and adequately precise means and variances during simultaneous estimation of complex, mechanistic models in a 45 dimensional parameter space with rich or sparse data using poor initial estimates. The Monte Carlo Parametric Expectation Maximization (MC-PEM) algorithm can approximate the true log-likelihood as precisely as needed and is efficiently parallelizable. Our objectives were to evaluate an importance sampling version of the MC-PEM algorithm for mechanistic models and to qualify the default estimation settings in SADAPT-TRAN. We assessed bias, imprecision and robustness of this algorithm in S-ADAPT for mechanistic models with up to 45 simultaneously estimated structural parameters, 14 differential equations, and 10 dependent variables (one drug concentration and nine pharmacodynamic effects). Simpler models comprising 15 parameters were estimated using three of the ten dependent variables. We set initial estimates to 0.1 or 10 times the true value and evaluated 30 bootstrap replicates with frequent or sparse sampling. Datasets comprised three dose levels with 16 subjects each. For simultaneous estimation of the full model, the ratio of estimated to true values for structural model parameters (median [5-95% percentile] over 45 parameters) was 1.01 [0.94-1.13] for means and 0.99 [0.68-1.39] for between-subject variances for frequent sampling and 1.02 [0.81-1.47] for means and 1.02 [0.47-2.56] for variances for sparse sampling. Imprecision was ≤25% for 43 of 45 means for frequent sampling. Bias and imprecision was well comparable for the full and simpler models. Parallelized estimation was 23-fold (6.9-fold) faster using 48 threads (eight threads) relative to one thread. The MC-PEM algorithm was robust and provided unbiased and adequately precise means and variances during simultaneous estimation of complex, mechanistic models in a 45 dimensional parameter space with rich or sparse data using poor initial estimates.The Monte Carlo Parametric Expectation Maximization (MC-PEM) algorithm can approximate the true log-likelihood as precisely as needed and is efficiently parallelizable. Our objectives were to evaluate an importance sampling version of the MC-PEM algorithm for mechanistic models and to qualify the default estimation settings in SADAPT-TRAN. We assessed bias, imprecision and robustness of this algorithm in S-ADAPT for mechanistic models with up to 45 simultaneously estimated structural parameters, 14 differential equations, and 10 dependent variables (one drug concentration and nine pharmacodynamic effects). Simpler models comprising 15 parameters were estimated using three of the ten dependent variables. We set initial estimates to 0.1 or 10 times the true value and evaluated 30 bootstrap replicates with frequent or sparse sampling. Datasets comprised three dose levels with 16 subjects each. For simultaneous estimation of the full model, the ratio of estimated to true values for structural model parameters (median [5-95% percentile] over 45 parameters) was 1.01 [0.94-1.13] for means and 0.99 [0.68-1.39] for between-subject variances for frequent sampling and 1.02 [0.81-1.47] for means and 1.02 [0.47-2.56] for variances for sparse sampling. Imprecision was ≤25% for 43 of 45 means for frequent sampling. Bias and imprecision was well comparable for the full and simpler models. Parallelized estimation was 23-fold (6.9-fold) faster using 48 threads (eight threads) relative to one thread. The MC-PEM algorithm was robust and provided unbiased and adequately precise means and variances during simultaneous estimation of complex, mechanistic models in a 45 dimensional parameter space with rich or sparse data using poor initial estimates.  | 
    
| Author | Bulitta, Jurgen B. Landersdorfer, Cornelia B.  | 
    
| Author_xml | – sequence: 1 givenname: Jurgen B. surname: Bulitta fullname: Bulitta, Jurgen B. email: j@bulitta.com organization: Ordway Research Institute, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo – sequence: 2 givenname: Cornelia B. surname: Landersdorfer fullname: Landersdorfer, Cornelia B. organization: Ordway Research Institute, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo  | 
    
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21374103$$D View this record in MEDLINE/PubMed | 
    
| BookMark | eNqNkd9uFCEUxompse3qA3hjuPNqFBhmhrkxWdd_TbpxY9trwjBnd2kYGIFR60v4yrLdtaleNF4Bh-87H-fHKTpy3gFCzyl5RRkRryNljIuCUFq0rBJF-wid0KoiRcNpfXRvf4xOY7wmpGQlpU_QMaNlLpPyBP1aQVj7MCinASvX4y--m2JyECP2a5y2gJfeJcALFazHZ8PoQ7oVX6hhtMZt8NxufDBpO-CruDuvVFDWgjU_occXxfzdfHWJcwZ-q6LRtyELn73wAy9Bb5UzMeX60vdg41P0eK1shGeHdYauPry_XHwqzj9_PFvMzwvNOU1FU3IOfd8RCgBNTTVwaGnJqKq7mhNVkZ7lQkMo6zOpuheqE7UQrRBdC6QpZ4jt-05uVDff84PlGMygwo2kRO7oyj1dmenKHV3ZZtObvWmcugF6DS7lUe-MXhn5940zW7nx32RJRNVk_DP08tAg-K8TxCQHEzVYqxz4KUpR80bwirCsfHE_6i7jz89lQbMX6OBjDLCW2iSVjN8lG_vgFPQf5_9MfsAVs9ZtIMhrPwWXf-gB0285t83W | 
    
| CitedBy_id | crossref_primary_10_1208_s12248_015_9764_2 crossref_primary_10_1016_j_jconrel_2016_02_042 crossref_primary_10_1128_AAC_01268_17 crossref_primary_10_1208_s12248_017_0138_9 crossref_primary_10_1007_s10928_014_9359_z crossref_primary_10_1093_jac_dku567 crossref_primary_10_1128_AAC_00259_15 crossref_primary_10_1093_cid_cit334 crossref_primary_10_1128_AAC_01741_13 crossref_primary_10_1128_AAC_01354_12 crossref_primary_10_1016_j_xphs_2023_10_029 crossref_primary_10_1128_AAC_01679_19 crossref_primary_10_1371_journal_pcbi_1004782 crossref_primary_10_1177_2050312118813283 crossref_primary_10_1128_AAC_00028_18 crossref_primary_10_1208_s12248_013_9524_0 crossref_primary_10_1128_aac_01393_23 crossref_primary_10_1002_jps_24412 crossref_primary_10_1128_AAC_02642_16 crossref_primary_10_1128_AAC_00092_13 crossref_primary_10_4155_bio_2018_0078 crossref_primary_10_1128_AAC_01150_18 crossref_primary_10_1155_2014_402126 crossref_primary_10_1128_AAC_00722_17 crossref_primary_10_1128_AAC_02176_18 crossref_primary_10_1007_s11095_019_2732_2 crossref_primary_10_1016_j_ejps_2018_05_017 crossref_primary_10_1128_AAC_02053_17 crossref_primary_10_1016_j_aquaculture_2023_740222 crossref_primary_10_1128_AAC_01934_16 crossref_primary_10_1128_AAC_00937_12 crossref_primary_10_3390_molecules22091488 crossref_primary_10_1007_s11095_023_03472_6 crossref_primary_10_1128_aac_01394_23 crossref_primary_10_1093_jac_dkv031 crossref_primary_10_1128_AAC_01965_17 crossref_primary_10_1128_aac_00414_23 crossref_primary_10_1007_s10856_015_5444_0 crossref_primary_10_1016_j_ejps_2017_06_008 crossref_primary_10_1128_AAC_00078_18 crossref_primary_10_3390_microorganisms9020307 crossref_primary_10_1093_cid_ciae093 crossref_primary_10_1021_acsptsci_0c00045 crossref_primary_10_1093_jac_dks201 crossref_primary_10_1007_s40262_012_0012_y crossref_primary_10_1128_AAC_02377_15 crossref_primary_10_1021_acs_molpharmaceut_5b00749 crossref_primary_10_1093_jac_dkac124 crossref_primary_10_1128_AAC_01011_16 crossref_primary_10_1128_AAC_03510_14 crossref_primary_10_1016_j_ejps_2018_07_054 crossref_primary_10_1093_jac_dkw293 crossref_primary_10_1128_AAC_01885_13 crossref_primary_10_1128_AAC_00211_17 crossref_primary_10_1016_j_ejps_2015_07_017 crossref_primary_10_1128_AAC_04379_14 crossref_primary_10_1016_j_ejps_2017_10_018 crossref_primary_10_1016_j_actbio_2023_12_002 crossref_primary_10_1002_psp4_12714 crossref_primary_10_1093_jac_dkx409 crossref_primary_10_1093_jac_dkw153 crossref_primary_10_3390_pharmaceutics11070323 crossref_primary_10_1111_jvp_12091 crossref_primary_10_1128_AAC_02307_18 crossref_primary_10_1016_j_ijantimicag_2025_107488 crossref_primary_10_1093_jac_dkw355 crossref_primary_10_1007_s40262_016_0430_3 crossref_primary_10_1016_j_ijpharm_2022_121624 crossref_primary_10_1128_aac_00197_23 crossref_primary_10_1128_AAC_00967_18 crossref_primary_10_1128_aac_01400_23 crossref_primary_10_1128_AAC_02055_17 crossref_primary_10_1128_aac_01081_23 crossref_primary_10_1093_cid_ciz067 crossref_primary_10_1128_AAC_00952_16 crossref_primary_10_1007_s10928_017_9554_9 crossref_primary_10_1128_AAC_04099_14 crossref_primary_10_1016_j_cmi_2020_02_004 crossref_primary_10_1128_AAC_02927_15 crossref_primary_10_1128_AAC_05453_11 crossref_primary_10_1016_j_cmi_2020_04_039 crossref_primary_10_1128_aac_01399_23 crossref_primary_10_3390_pharmaceutics11060286 crossref_primary_10_1128_AAC_00973_17  | 
    
| Cites_doi | 10.2307/2684170 10.1124/jpet.110.167304 10.1007/s00280-008-0827-2 10.1023/A:1020707208521 10.1023/B:JOPA.0000042738.06821.61 10.2307/2533054 10.2165/11318090-000000000-00000 10.1051/ps:2004007 10.1038/clpt.2009.87 10.2165/00003088-200645040-00003 10.1038/sj.clpt.6100476 10.1016/j.csda.2007.03.008 10.1023/A:1012299115260 10.1124/jpet.108.137372 10.1002/(SICI)1097-0258(19970615)16:11<1241::AID-SIM527>3.0.CO;2-C 10.1208/ps020332 10.1214/aos/1018031103 10.2165/00003088-199834010-00003 10.1214/aos/1176346060 10.1023/A:1011517718990 10.1023/A:1025542026488 10.1038/clpt.2008.52 10.1016/0096-3003(91)90077-Z 10.1137/0904010 10.1016/j.toxicon.2008.08.013 10.1208/aapsj0901007 10.2307/2286284 10.1007/BF01061030 10.1081/BIP-200040824 10.1124/jpet.108.137703 10.1007/s10928-009-9126-8 10.1128/AAC.00881-09 10.1007/BF01060053 10.1124/jpet.108.144766 10.1023/A:1023573429626 10.1016/0010-468X(79)90025-4 10.1007/s11095-005-5642-4 10.3109/03602538409015066 10.1208/s12248-007-9006-3 10.1007/s00280-009-1023-8 10.1128/AAC.00489-08 10.1007/s00280-010-1393-y 10.1111/j.2517-6161.1977.tb01600.x  | 
    
| ContentType | Journal Article | 
    
| Copyright | American Association of Pharmaceutical Scientists 2011 | 
    
| Copyright_xml | – notice: American Association of Pharmaceutical Scientists 2011 | 
    
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ADTOC UNPAY  | 
    
| DOI | 10.1208/s12248-011-9258-9 | 
    
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall  | 
    
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic  | 
    
| DatabaseTitleList | MEDLINE MEDLINE - Academic  | 
    
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository  | 
    
| DeliveryMethod | fulltext_linktorsrc | 
    
| Discipline | Pharmacy, Therapeutics, & Pharmacology | 
    
| EISSN | 1550-7416 | 
    
| EndPage | 226 | 
    
| ExternalDocumentID | 10.1208/s12248-011-9258-9 PMC3085700 21374103 10_1208_s12248_011_9258_9  | 
    
| Genre | Journal Article | 
    
| GroupedDBID | --- -56 -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 123 1N0 203 23M 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 4.4 406 408 40D 40E 53G 67N 6J9 6NX 875 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AAKDD AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABDZT ABECU ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMJI ACMLO ACOKC ACOMO ACPIV ACREN ACSNA ACZOJ ADBBV ADHIR ADINQ ADKNI ADKPE ADQRH ADRFC ADURQ ADYFF ADYOE ADZKW AEBTG AEFQL AEGAL AEGNC AEGXH AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFGCZ AFLOW AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWZB AGYKE AHAVH AHBYD AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AOCGG AOIJS ARMRJ AXYYD B-. BA0 BAWUL BDATZ BGNMA C1A CAG COF CS3 CSCUP DDRTE DIK DNIVK DPUIP E3Z EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GX1 H13 HG6 HH5 HMJXF HRMNR HYE HZ~ IAO IEA IHR IJ- IKXTQ IWAJR IXC IXD I~X I~Z J-C J0Z JBSCW JZLTJ KOV KPH LGEZI LLZTM LOTEE M4Y MA- MK0 NADUK NPVJJ NQJWS NU0 NXXTH O9- O93 O9I O9J OK1 P6G PF0 PT4 PT5 QOR QOS R89 R9I ROL RPM RPX RSV S16 S1Z S27 S3A S3B SAP SBL SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 TSG TSV TUC U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 XSB YLTOR Z45 Z7U Z7V Z7W Z7X Z81 Z83 Z87 ZMTXR ZOVNA ~A9 AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ADTOC UNPAY  | 
    
| ID | FETCH-LOGICAL-c441t-7344eddb01eee761ce4e91321a6b640a50d2e917012d2086d8ab8688988b9e073 | 
    
| IEDL.DBID | U2A | 
    
| ISSN | 1550-7416 | 
    
| IngestDate | Wed Oct 01 16:40:49 EDT 2025 Thu Aug 21 18:20:32 EDT 2025 Fri Sep 05 14:14:57 EDT 2025 Mon Jul 21 06:05:17 EDT 2025 Wed Oct 01 06:46:20 EDT 2025 Thu Apr 24 22:54:03 EDT 2025 Fri Feb 21 02:33:47 EST 2025  | 
    
| IsDoiOpenAccess | true | 
    
| IsOpenAccess | true | 
    
| IsPeerReviewed | true | 
    
| IsScholarly | true | 
    
| Issue | 2 | 
    
| Keywords | mechanistic population pharmacokinetic Monte Carlo importance sampling nonlinear mixed-effects modeling in S-ADAPT pharmacodynamic modeling parallel computing Monte Carlo parametric expectation maximization (MC-PEM) algorithm  | 
    
| Language | English | 
    
| License | http://www.springer.com/tdm | 
    
| LinkModel | DirectLink | 
    
| MergedId | FETCHMERGED-LOGICAL-c441t-7344eddb01eee761ce4e91321a6b640a50d2e917012d2086d8ab8688988b9e073 | 
    
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23  | 
    
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://link.springer.com/content/pdf/10.1208/s12248-011-9258-9.pdf | 
    
| PMID | 21374103 | 
    
| PQID | 864784502 | 
    
| PQPubID | 23479 | 
    
| PageCount | 15 | 
    
| ParticipantIDs | unpaywall_primary_10_1208_s12248_011_9258_9 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3085700 proquest_miscellaneous_864784502 pubmed_primary_21374103 crossref_citationtrail_10_1208_s12248_011_9258_9 crossref_primary_10_1208_s12248_011_9258_9 springer_journals_10_1208_s12248_011_9258_9  | 
    
| ProviderPackageCode | CITATION AAYXX  | 
    
| PublicationCentury | 2000 | 
    
| PublicationDate | 2011-06-01 | 
    
| PublicationDateYYYYMMDD | 2011-06-01 | 
    
| PublicationDate_xml | – month: 06 year: 2011 text: 2011-06-01 day: 01  | 
    
| PublicationDecade | 2010 | 
    
| PublicationPlace | Boston | 
    
| PublicationPlace_xml | – name: Boston – name: United States  | 
    
| PublicationSubtitle | An Official Journal of the American Association of Pharmaceutical Scientists | 
    
| PublicationTitle | The AAPS journal | 
    
| PublicationTitleAbbrev | AAPS J | 
    
| PublicationTitleAlternate | AAPS J | 
    
| PublicationYear | 2011 | 
    
| Publisher | Springer US | 
    
| Publisher_xml | – name: Springer US | 
    
| References | Earp, Dubois, Molano, Pyszczynski, Keller, Almon (CR21) 2008; 326 Kuhn, Lavielle (CR53) 2004; 8 Petzold (CR50) 1983; 4 Landersdorfer, DuBois, Almon, Jusko (CR22) 2009; 328 Duffull, Kirkpatrick, Green, Holford (CR44) 2005; 15 Mager, Jusko (CR25) 2008; 83 Wu (CR6) 1983; 11 Schumitzky (CR10) 1991; 45 Xu, Eiseman, Egorin, D’Argenio (CR37) 2003; 30 Delyon, Lavielle, Moulines (CR52) 1999; 27 Beal, Sheiner, Boeckmann, Bauer (CR16) 2009 Friberg, Karlsson (CR30) 2003; 21 Plan, Maloney, Troconiz, Karlsson (CR46) 2009; 36 Ait-Oudhia, Scherrmann, Krzyzanski (CR23) 2010; 334 Sheiner, Beal (CR41) 1981; 9 Bulitta, Zhao, Arnold, Kessler, Daifuku, Pratt (CR32) 2009; 63 Fung, Tsou, Bulitta, Tran, Page, Soda (CR36) 2008; 10 Wiczling, Lowe, Pigeolet, Ludicke, Balser, Krzyzanski (CR33) 2009; 48 CR8 Beal (CR39) 2001; 28 Ng, Patnaik, Beeram, Lin, Takimoto (CR28) 2010 Tanos, Isbister, Lalloo, Kirkpatrick, Duffull (CR34) 2008; 52 Bauer, Guzy, Ng (CR4) 2007; 9 Smith, Gelfand (CR17) 1992; 46 Bulitta, Ly, Yang, Forrest, Jusko, Tsuji (CR26) 2009; 53 Jonsson, Wade, Karlsson (CR47) 2000; 2 Krzyzanski, Jusko (CR49) 2001; 28 Krzyzanski, Jusko (CR48) 1998; 26 Wajima, Isbister, Duffull (CR35) 2009; 86 Jonsson, Kjellsson, Karlsson (CR45) 2004; 31 Laird (CR11) 1978; 73 Bauer, Guzy, D’Argenio (CR18) 2003 CR19 D’Argenio, Schumitzky (CR14) 1979; 9 Sheiner, Beal (CR40) 1980; 8 CR15 CR13 Ng, Bai, Takimoto, Tang, Tolcher (CR29) 2009; 65 CR12 CR51 Bustad, Terziivanov, Leary, Port, Schumitzky, Jelliffe (CR7) 2006; 45 Jelliffe, Schumitzky, Bayard, Milman, Van Guilder, Wang (CR9) 1998; 34 Bulitta, Yang, Yohonn, Ly, Brown, D’Hondt (CR24) 2010; 54 Dempster, Laird, Rubin (CR1) 1977; 39 Steimer, Mallet, Golmard, Boisvieux (CR42) 1984; 15 Hooker, Ten Tije, Carducci, Weber, Garrett-Mayer, Gelderblom (CR31) 2008; 84 Schumitzky, D’Argenio (CR2) 1995 Wang, Schumitzky, D’Argenio (CR5) 2007; 51 CR20 Walker (CR3) 1996; 52 Ng, Joshi, Dedrick, Garovoy, Bauer (CR27) 2005; 22 Marathe, Peterson, Mager (CR38) 2008; 326 Roe (CR43) 1997; 16 A Schumitzky (9258_CR10) 1991; 45 L Xu (9258_CR37) 2003; 30 B Delyon (9258_CR52) 1999; 27 AFM Smith (9258_CR17) 1992; 46 RJ Bauer (9258_CR4) 2007; 9 9258_CR20 LE Friberg (9258_CR30) 2003; 21 C-FJ Wu (9258_CR6) 1983; 11 N Laird (9258_CR11) 1978; 73 DZ D’Argenio (9258_CR14) 1979; 9 S Jonsson (9258_CR45) 2004; 31 CM Ng (9258_CR27) 2005; 22 LR Petzold (9258_CR50) 1983; 4 9258_CR8 AC Hooker (9258_CR31) 2008; 84 P Wiczling (9258_CR33) 2009; 48 EL Plan (9258_CR46) 2009; 36 HL Fung (9258_CR36) 2008; 10 X Wang (9258_CR5) 2007; 51 A Schumitzky (9258_CR2) 1995 A Bustad (9258_CR7) 2006; 45 W Krzyzanski (9258_CR48) 1998; 26 DJ Roe (9258_CR43) 1997; 16 SL Beal (9258_CR16) 2009 JB Bulitta (9258_CR32) 2009; 63 AP Dempster (9258_CR1) 1977; 39 RJ Bauer (9258_CR18) 2003 W Krzyzanski (9258_CR49) 2001; 28 E Kuhn (9258_CR53) 2004; 8 PP Tanos (9258_CR34) 2008; 52 JB Bulitta (9258_CR24) 2010; 54 LB Sheiner (9258_CR40) 1980; 8 DE Mager (9258_CR25) 2008; 83 EN Jonsson (9258_CR47) 2000; 2 RW Jelliffe (9258_CR9) 1998; 34 JB Bulitta (9258_CR26) 2009; 53 CM Ng (9258_CR29) 2009; 65 SL Beal (9258_CR39) 2001; 28 SB Duffull (9258_CR44) 2005; 15 9258_CR51 CM Ng (9258_CR28) 2010 LB Sheiner (9258_CR41) 1981; 9 A Marathe (9258_CR38) 2008; 326 9258_CR19 JC Earp (9258_CR21) 2008; 326 S Ait-Oudhia (9258_CR23) 2010; 334 S Walker (9258_CR3) 1996; 52 9258_CR12 JL Steimer (9258_CR42) 1984; 15 T Wajima (9258_CR35) 2009; 86 9258_CR15 9258_CR13 CB Landersdorfer (9258_CR22) 2009; 328 20211900 - Antimicrob Agents Chemother. 2010 May;54(5):2051-62 15702605 - J Biopharm Stat. 2005;15(1):53-73 7229908 - J Pharmacokinet Biopharm. 1980 Dec;8(6):553-71 18852268 - Antimicrob Agents Chemother. 2009 Jan;53(1):46-56 19516255 - Clin Pharmacol Ther. 2009 Sep;86(3):290-8 18971370 - J Pharmacol Exp Ther. 2009 Feb;328(2):644-51 18446506 - AAPS J. 2008;10(1):56-69 14571691 - J Pharmacokinet Pharmacodyn. 2003 Jun;30(3):185-219 10485083 - J Pharmacokinet Biopharm. 1998 Dec;26(6):735-41 9474473 - Clin Pharmacokinet. 1998 Jan;34(1):57-77 6745083 - Drug Metab Rev. 1984;15(1-2):265-92 11253614 - J Pharmacokinet Pharmacodyn. 2001 Feb;28(1):57-78 11741248 - AAPS PharmSci. 2000;2(3):E32 20501635 - J Pharmacol Exp Ther. 2010 Sep 1;334(3):897-910 7334463 - J Pharmacokinet Biopharm. 1981 Oct;9(5):635-51 18460643 - J Pharmacol Exp Ther. 2008 Aug;326(2):555-62 19756256 - Comput Stat Data Anal. 2007 Aug 15;51(12):6614-6623 11768292 - J Pharmacokinet Pharmacodyn. 2001 Oct;28(5):481-504 1807753 - Proc Annu Symp Comput Appl Med Care. 1991;:922-4 18831981 - Toxicon. 2008 Dec 1;52(7):769-80 12889739 - Invest New Drugs. 2003 May;21(2):183-94 19468731 - Cancer Chemother Pharmacol. 2010 Jan;65(2):207-17 19902989 - Clin Pharmacokinet. 2009;48(12):817-26 761456 - Comput Programs Biomed. 1979 Mar;9(2):115-34 9194270 - Stat Med. 1997 Jun 15;16(11):1241-57; discussion 1257-62 16584284 - Clin Pharmacokinet. 2006;45(4):365-83 20614121 - Cancer Chemother Pharmacol. 2011 May;67(5):985-94 16028009 - Pharm Res. 2005 Jul;22(7):1088-100 15563005 - J Pharmacokinet Pharmacodyn. 2004 Aug;31(4):299-320 18388873 - Clin Pharmacol Ther. 2008 Jun;83(6):909-12 18791718 - Cancer Chemother Pharmacol. 2009 May;63(6):1049-63 18448865 - J Pharmacol Exp Ther. 2008 Aug;326(2):532-45 19653080 - J Pharmacokinet Pharmacodyn. 2009 Aug;36(4):353-66 18183036 - Clin Pharmacol Ther. 2008 Jul;84(1):111-8 17408237 - AAPS J. 2007;9(1):E60-83  | 
    
| References_xml | – volume: 46 start-page: 84 year: 1992 end-page: 88 ident: CR17 article-title: Bayesian statistics without tears: a sampling–resampling perspective publication-title: Am Stat doi: 10.2307/2684170 – volume: 334 start-page: 897 year: 2010 end-page: 910 ident: CR23 article-title: Simultaneous pharmacokinetics/pharmacodynamics modeling of recombinant human erythropoietin upon multiple intravenous dosing in rats publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.110.167304 – volume: 63 start-page: 1049 year: 2009 end-page: 63 ident: CR32 article-title: Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation Taxol in cancer patients publication-title: Cancer Chemother Pharmacol doi: 10.1007/s00280-008-0827-2 – volume: 26 start-page: 735 year: 1998 end-page: 41 ident: CR48 article-title: Note: caution in use of empirical equations for pharmacodynamic indirect response models publication-title: J Pharmacokinet Biopharm doi: 10.1023/A:1020707208521 – start-page: 135 year: 2003 end-page: 63 ident: CR18 article-title: Monte Carlo parametric expectation maximization (MC-PEM) method for analyzing population pharmacokinetic/pharmacodynamic data publication-title: Advanced methods of pharmacokinetic and pharmacodynamic systems analysis – volume: 31 start-page: 299 year: 2004 end-page: 320 ident: CR45 article-title: Estimating bias in population parameters for some models for repeated measures ordinal data using NONMEM and NLMIXED publication-title: J Pharmacokinet Pharmacodyn doi: 10.1023/B:JOPA.0000042738.06821.61 – start-page: 145 year: 1995 end-page: 60 ident: CR2 article-title: EM algorithms and two-stage methods in pharmacokinetic population analysis publication-title: Advanced methods of pharmacokinetic and pharmacodynamic systems analysis – volume: 52 start-page: 934 year: 1996 end-page: 44 ident: CR3 article-title: An EM algorithm for nonlinear random effects models publication-title: Biometrics doi: 10.2307/2533054 – volume: 48 start-page: 817 year: 2009 end-page: 26 ident: CR33 article-title: Population pharmacokinetic modelling of filgrastim in healthy adults following intravenous and subcutaneous administrations publication-title: Clin Pharmacokinet doi: 10.2165/11318090-000000000-00000 – ident: CR51 – ident: CR12 – volume: 8 start-page: 115 year: 2004 end-page: 31 ident: CR53 article-title: Coupling a stochastic approximation version of EM with a MCMC procedure publication-title: ESAIM Probab Stat doi: 10.1051/ps:2004007 – volume: 86 start-page: 290 year: 2009 end-page: 8 ident: CR35 article-title: A comprehensive model for the humoral coagulation network in humans publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2009.87 – volume: 45 start-page: 365 year: 2006 end-page: 83 ident: CR7 article-title: Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies publication-title: Clin Pharmacokinet doi: 10.2165/00003088-200645040-00003 – ident: CR8 – volume: 84 start-page: 111 year: 2008 end-page: 8 ident: CR31 article-title: Population pharmacokinetic model for docetaxel in patients with varying degrees of liver function: incorporating cytochrome P4503A activity measurements publication-title: Clin Pharmacol Ther doi: 10.1038/sj.clpt.6100476 – volume: 51 start-page: 6614 year: 2007 end-page: 23 ident: CR5 article-title: Nonlinear random effects mixture models: maximum likelihood estimation via the EM algorithm publication-title: Comput Stat Data Anal doi: 10.1016/j.csda.2007.03.008 – volume: 28 start-page: 481 year: 2001 end-page: 504 ident: CR39 article-title: Ways to fit a PK model with some data below the quantification limit publication-title: J Pharmacokinet Pharmacodyn doi: 10.1023/A:1012299115260 – ident: CR19 – ident: CR15 – volume: 326 start-page: 532 year: 2008 end-page: 45 ident: CR21 article-title: Modeling corticosteroid effects in a rat model of rheumatoid arthritis I: mechanistic disease progression model for the time course of collagen-induced arthritis in Lewis rats publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.108.137372 – volume: 16 start-page: 1241 year: 1997 end-page: 57 ident: CR43 article-title: Comparison of population pharmacokinetic modeling methods using simulated data: results from the Population Modeling Workgroup publication-title: Stat Med doi: 10.1002/(SICI)1097-0258(19970615)16:11<1241::AID-SIM527>3.0.CO;2-C – volume: 2 start-page: E32 year: 2000 ident: CR47 article-title: Nonlinearity detection: advantages of nonlinear mixed-effects modeling publication-title: AAPS PharmSci doi: 10.1208/ps020332 – volume: 27 start-page: 94 year: 1999 end-page: 128 ident: CR52 article-title: Convergence of a stochastic approximation version of the EM algorithm publication-title: Ann Stat doi: 10.1214/aos/1018031103 – volume: 34 start-page: 57 year: 1998 end-page: 77 ident: CR9 article-title: Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new ‘multiple model’ dosage design, Bayesian feedback and individualised target goals publication-title: Clin Pharmacokinet doi: 10.2165/00003088-199834010-00003 – volume: 11 start-page: 95 year: 1983 end-page: 103 ident: CR6 article-title: On the convergence properties of the EM algorithm publication-title: Ann Stat doi: 10.1214/aos/1176346060 – year: 2010 ident: CR28 article-title: Mechanism-based pharmacokinetic/pharmacodynamic model for troxacitabine-induced neutropenia in cancer patients publication-title: Cancer Chemother Pharmacol – volume: 28 start-page: 57 year: 2001 end-page: 78 ident: CR49 article-title: Indirect pharmacodynamic models for responses with multicompartmental distribution or polyexponential disposition publication-title: J Pharmacokinet Pharmacodyn doi: 10.1023/A:1011517718990 – volume: 30 start-page: 185 year: 2003 end-page: 219 ident: CR37 article-title: Physiologically-based pharmacokinetics and molecular pharmacodynamics of 17-(allylamino)-17-demethoxygeldanamycin and its active metabolite in tumor-bearing mice publication-title: J Pharmacokinet Pharmacodyn doi: 10.1023/A:1025542026488 – volume: 83 start-page: 909 year: 2008 end-page: 12 ident: CR25 article-title: Development of translational pharmacokinetic–pharmacodynamic models publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2008.52 – volume: 45 start-page: 143 year: 1991 end-page: 57 ident: CR10 article-title: Nonparametric EM algorithms for estimating prior distributions publication-title: Appl Math Comput doi: 10.1016/0096-3003(91)90077-Z – volume: 4 start-page: 136 year: 1983 end-page: 48 ident: CR50 article-title: Automatic selection of methods for solving stiff and nonstiff systems of ordinary diferential equations publication-title: Siam J Sci Stat Comput doi: 10.1137/0904010 – volume: 52 start-page: 769 year: 2008 end-page: 80 ident: CR34 article-title: A model for venom-induced consumptive coagulopathy in snake bite publication-title: Toxicon doi: 10.1016/j.toxicon.2008.08.013 – volume: 9 start-page: E60 year: 2007 end-page: 83 ident: CR4 article-title: A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples publication-title: AAPS J doi: 10.1208/aapsj0901007 – volume: 73 start-page: 805 year: 1978 end-page: 11 ident: CR11 article-title: Nonparametric maximum likelihood estimation of a mixing distribution publication-title: J Amer Stat Assn doi: 10.2307/2286284 – volume: 9 start-page: 635 year: 1981 end-page: 51 ident: CR41 article-title: Evaluation of methods for estimating population pharmacokinetic parameters II. Biexponential model and experimental pharmacokinetic data publication-title: J Pharmacokinet Biopharm doi: 10.1007/BF01061030 – volume: 15 start-page: 53 year: 2005 end-page: 73 ident: CR44 article-title: Analysis of population pharmacokinetic data using NONMEM and WinBUGS publication-title: J Biopharm Stat doi: 10.1081/BIP-200040824 – volume: 326 start-page: 555 year: 2008 end-page: 62 ident: CR38 article-title: Integrated cellular bone homeostasis model for denosumab pharmacodynamics in multiple myeloma patients publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.108.137703 – volume: 36 start-page: 353 year: 2009 end-page: 66 ident: CR46 article-title: Performance in population models for count data, part I: maximum likelihood approximations publication-title: J Pharmacokinet Pharmacodyn doi: 10.1007/s10928-009-9126-8 – volume: 54 start-page: 2051 year: 2010 end-page: 62 ident: CR24 article-title: Attenuation of colistin bactericidal activity by high inoculum of characterized by a new mechanism-based population pharmacodynamic model publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00881-09 – volume: 8 start-page: 553 year: 1980 end-page: 71 ident: CR40 article-title: Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis–Menten model: routine clinical pharmacokinetic data publication-title: J Pharmacokinet Biopharm doi: 10.1007/BF01060053 – volume: 328 start-page: 644 year: 2009 end-page: 51 ident: CR22 article-title: Mechanism-based modeling of nutritional and leptin influences on growth in normal and type 2 diabetic rats publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.108.144766 – volume: 21 start-page: 183 year: 2003 end-page: 94 ident: CR30 article-title: Mechanistic models for myelosuppression publication-title: Investig New Drugs doi: 10.1023/A:1023573429626 – ident: CR13 – volume: 9 start-page: 115 year: 1979 end-page: 34 ident: CR14 article-title: A program package for simulation and parameter estimation in pharmacokinetic systems publication-title: Comput Programs Biomed doi: 10.1016/0010-468X(79)90025-4 – volume: 22 start-page: 1088 year: 2005 end-page: 100 ident: CR27 article-title: Pharmacokinetic–pharmacodynamic efficacy analysis of efalizumab in patients with moderate to severe psoriasis publication-title: Pharm Res doi: 10.1007/s11095-005-5642-4 – volume: 15 start-page: 265 year: 1984 end-page: 92 ident: CR42 article-title: Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model publication-title: Drug Metab Rev doi: 10.3109/03602538409015066 – volume: 10 start-page: 56 year: 2008 end-page: 69 ident: CR36 article-title: Pharmacokinetics of 1, 4-butanediol in rats: bioactivation to gamma-hydroxybutyric acid, interaction with ethanol, and oral bioavailability publication-title: AAPS J doi: 10.1208/s12248-007-9006-3 – year: 2009 ident: CR16 publication-title: NONMEM user’s guides (1989–2009) – volume: 65 start-page: 207 year: 2009 end-page: 217 ident: CR29 article-title: Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-alpha(5)beta (1) integrin monoclonal antibody (volociximab) in cancer patients publication-title: Cancer Chemother Pharmacol doi: 10.1007/s00280-009-1023-8 – volume: 39 start-page: 1 year: 1977 end-page: 38 ident: CR1 article-title: Maximum likelihood from incomplete data via the EM algorithm publication-title: J R Stat Soc B – volume: 53 start-page: 46 year: 2009 end-page: 56 ident: CR26 article-title: Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00489-08 – ident: CR20 – volume: 326 start-page: 555 year: 2008 ident: 9258_CR38 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.108.137703 – volume-title: NONMEM user’s guides (1989–2009) year: 2009 ident: 9258_CR16 – volume: 21 start-page: 183 year: 2003 ident: 9258_CR30 publication-title: Investig New Drugs doi: 10.1023/A:1023573429626 – volume: 9 start-page: E60 year: 2007 ident: 9258_CR4 publication-title: AAPS J doi: 10.1208/aapsj0901007 – volume: 9 start-page: 635 year: 1981 ident: 9258_CR41 publication-title: J Pharmacokinet Biopharm doi: 10.1007/BF01061030 – ident: 9258_CR15 – ident: 9258_CR19 – volume: 4 start-page: 136 year: 1983 ident: 9258_CR50 publication-title: Siam J Sci Stat Comput doi: 10.1137/0904010 – volume: 45 start-page: 143 year: 1991 ident: 9258_CR10 publication-title: Appl Math Comput doi: 10.1016/0096-3003(91)90077-Z – ident: 9258_CR12 – volume: 15 start-page: 53 year: 2005 ident: 9258_CR44 publication-title: J Biopharm Stat doi: 10.1081/BIP-200040824 – volume: 2 start-page: E32 year: 2000 ident: 9258_CR47 publication-title: AAPS PharmSci doi: 10.1208/ps020332 – volume: 52 start-page: 934 year: 1996 ident: 9258_CR3 publication-title: Biometrics doi: 10.2307/2533054 – volume: 328 start-page: 644 year: 2009 ident: 9258_CR22 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.108.144766 – volume: 36 start-page: 353 year: 2009 ident: 9258_CR46 publication-title: J Pharmacokinet Pharmacodyn doi: 10.1007/s10928-009-9126-8 – volume: 34 start-page: 57 year: 1998 ident: 9258_CR9 publication-title: Clin Pharmacokinet doi: 10.2165/00003088-199834010-00003 – volume: 8 start-page: 553 year: 1980 ident: 9258_CR40 publication-title: J Pharmacokinet Biopharm doi: 10.1007/BF01060053 – volume: 15 start-page: 265 year: 1984 ident: 9258_CR42 publication-title: Drug Metab Rev doi: 10.3109/03602538409015066 – volume: 30 start-page: 185 year: 2003 ident: 9258_CR37 publication-title: J Pharmacokinet Pharmacodyn doi: 10.1023/A:1025542026488 – volume: 9 start-page: 115 year: 1979 ident: 9258_CR14 publication-title: Comput Programs Biomed doi: 10.1016/0010-468X(79)90025-4 – volume: 86 start-page: 290 year: 2009 ident: 9258_CR35 publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2009.87 – volume: 54 start-page: 2051 year: 2010 ident: 9258_CR24 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00881-09 – ident: 9258_CR20 – volume: 46 start-page: 84 year: 1992 ident: 9258_CR17 publication-title: Am Stat doi: 10.2307/2684170 – ident: 9258_CR51 – volume: 28 start-page: 481 year: 2001 ident: 9258_CR39 publication-title: J Pharmacokinet Pharmacodyn doi: 10.1023/A:1012299115260 – volume: 51 start-page: 6614 year: 2007 ident: 9258_CR5 publication-title: Comput Stat Data Anal doi: 10.1016/j.csda.2007.03.008 – start-page: 135 volume-title: Advanced methods of pharmacokinetic and pharmacodynamic systems analysis year: 2003 ident: 9258_CR18 – ident: 9258_CR13 – year: 2010 ident: 9258_CR28 publication-title: Cancer Chemother Pharmacol doi: 10.1007/s00280-010-1393-y – volume: 53 start-page: 46 year: 2009 ident: 9258_CR26 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00489-08 – volume: 8 start-page: 115 year: 2004 ident: 9258_CR53 publication-title: ESAIM Probab Stat doi: 10.1051/ps:2004007 – start-page: 145 volume-title: Advanced methods of pharmacokinetic and pharmacodynamic systems analysis year: 1995 ident: 9258_CR2 – volume: 39 start-page: 1 year: 1977 ident: 9258_CR1 publication-title: J R Stat Soc B doi: 10.1111/j.2517-6161.1977.tb01600.x – volume: 22 start-page: 1088 year: 2005 ident: 9258_CR27 publication-title: Pharm Res doi: 10.1007/s11095-005-5642-4 – volume: 11 start-page: 95 year: 1983 ident: 9258_CR6 publication-title: Ann Stat doi: 10.1214/aos/1176346060 – volume: 27 start-page: 94 year: 1999 ident: 9258_CR52 publication-title: Ann Stat doi: 10.1214/aos/1018031103 – volume: 31 start-page: 299 year: 2004 ident: 9258_CR45 publication-title: J Pharmacokinet Pharmacodyn doi: 10.1023/B:JOPA.0000042738.06821.61 – volume: 26 start-page: 735 year: 1998 ident: 9258_CR48 publication-title: J Pharmacokinet Biopharm doi: 10.1023/A:1020707208521 – ident: 9258_CR8 – volume: 48 start-page: 817 year: 2009 ident: 9258_CR33 publication-title: Clin Pharmacokinet doi: 10.2165/11318090-000000000-00000 – volume: 84 start-page: 111 year: 2008 ident: 9258_CR31 publication-title: Clin Pharmacol Ther doi: 10.1038/sj.clpt.6100476 – volume: 73 start-page: 805 year: 1978 ident: 9258_CR11 publication-title: J Amer Stat Assn doi: 10.2307/2286284 – volume: 326 start-page: 532 year: 2008 ident: 9258_CR21 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.108.137372 – volume: 52 start-page: 769 year: 2008 ident: 9258_CR34 publication-title: Toxicon doi: 10.1016/j.toxicon.2008.08.013 – volume: 45 start-page: 365 year: 2006 ident: 9258_CR7 publication-title: Clin Pharmacokinet doi: 10.2165/00003088-200645040-00003 – volume: 83 start-page: 909 year: 2008 ident: 9258_CR25 publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2008.52 – volume: 28 start-page: 57 year: 2001 ident: 9258_CR49 publication-title: J Pharmacokinet Pharmacodyn doi: 10.1023/A:1011517718990 – volume: 334 start-page: 897 year: 2010 ident: 9258_CR23 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.110.167304 – volume: 10 start-page: 56 year: 2008 ident: 9258_CR36 publication-title: AAPS J doi: 10.1208/s12248-007-9006-3 – volume: 65 start-page: 207 year: 2009 ident: 9258_CR29 publication-title: Cancer Chemother Pharmacol doi: 10.1007/s00280-009-1023-8 – volume: 63 start-page: 1049 year: 2009 ident: 9258_CR32 publication-title: Cancer Chemother Pharmacol doi: 10.1007/s00280-008-0827-2 – volume: 16 start-page: 1241 year: 1997 ident: 9258_CR43 publication-title: Stat Med doi: 10.1002/(SICI)1097-0258(19970615)16:11<1241::AID-SIM527>3.0.CO;2-C – reference: 9474473 - Clin Pharmacokinet. 1998 Jan;34(1):57-77 – reference: 18831981 - Toxicon. 2008 Dec 1;52(7):769-80 – reference: 9194270 - Stat Med. 1997 Jun 15;16(11):1241-57; discussion 1257-62 – reference: 11768292 - J Pharmacokinet Pharmacodyn. 2001 Oct;28(5):481-504 – reference: 18446506 - AAPS J. 2008;10(1):56-69 – reference: 18183036 - Clin Pharmacol Ther. 2008 Jul;84(1):111-8 – reference: 19902989 - Clin Pharmacokinet. 2009;48(12):817-26 – reference: 12889739 - Invest New Drugs. 2003 May;21(2):183-94 – reference: 15563005 - J Pharmacokinet Pharmacodyn. 2004 Aug;31(4):299-320 – reference: 19653080 - J Pharmacokinet Pharmacodyn. 2009 Aug;36(4):353-66 – reference: 18388873 - Clin Pharmacol Ther. 2008 Jun;83(6):909-12 – reference: 18791718 - Cancer Chemother Pharmacol. 2009 May;63(6):1049-63 – reference: 20211900 - Antimicrob Agents Chemother. 2010 May;54(5):2051-62 – reference: 20501635 - J Pharmacol Exp Ther. 2010 Sep 1;334(3):897-910 – reference: 17408237 - AAPS J. 2007;9(1):E60-83 – reference: 16028009 - Pharm Res. 2005 Jul;22(7):1088-100 – reference: 15702605 - J Biopharm Stat. 2005;15(1):53-73 – reference: 761456 - Comput Programs Biomed. 1979 Mar;9(2):115-34 – reference: 11741248 - AAPS PharmSci. 2000;2(3):E32 – reference: 19756256 - Comput Stat Data Anal. 2007 Aug 15;51(12):6614-6623 – reference: 16584284 - Clin Pharmacokinet. 2006;45(4):365-83 – reference: 20614121 - Cancer Chemother Pharmacol. 2011 May;67(5):985-94 – reference: 18460643 - J Pharmacol Exp Ther. 2008 Aug;326(2):555-62 – reference: 6745083 - Drug Metab Rev. 1984;15(1-2):265-92 – reference: 7334463 - J Pharmacokinet Biopharm. 1981 Oct;9(5):635-51 – reference: 19516255 - Clin Pharmacol Ther. 2009 Sep;86(3):290-8 – reference: 14571691 - J Pharmacokinet Pharmacodyn. 2003 Jun;30(3):185-219 – reference: 18852268 - Antimicrob Agents Chemother. 2009 Jan;53(1):46-56 – reference: 19468731 - Cancer Chemother Pharmacol. 2010 Jan;65(2):207-17 – reference: 11253614 - J Pharmacokinet Pharmacodyn. 2001 Feb;28(1):57-78 – reference: 1807753 - Proc Annu Symp Comput Appl Med Care. 1991;:922-4 – reference: 10485083 - J Pharmacokinet Biopharm. 1998 Dec;26(6):735-41 – reference: 18448865 - J Pharmacol Exp Ther. 2008 Aug;326(2):532-45 – reference: 18971370 - J Pharmacol Exp Ther. 2009 Feb;328(2):644-51 – reference: 7229908 - J Pharmacokinet Biopharm. 1980 Dec;8(6):553-71  | 
    
| SSID | ssj0032311 | 
    
| Score | 2.2806053 | 
    
| Snippet | The Monte Carlo Parametric Expectation Maximization (MC-PEM) algorithm can approximate the true log-likelihood as precisely as needed and is efficiently... | 
    
| SourceID | unpaywall pubmedcentral proquest pubmed crossref springer  | 
    
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher  | 
    
| StartPage | 212 | 
    
| SubjectTerms | Algorithms Biochemistry Biomedical and Life Sciences Biomedicine Biotechnology Computer Simulation Models, Biological Monte Carlo Method Pharmaceutical Preparations - administration & dosage Pharmaceutical Preparations - metabolism Pharmacokinetics Pharmacology/Toxicology Pharmacy Research Article  | 
    
| SummonAdditionalLinks | – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEB6V9AAceJeal-aAeqB16vfjaAJVQUpl0UQqJ2vXXrdRXTuKbUH6J_jL7PiREIqKEFd71_Z6v9md2Zn5BuCtT-48jVuqxXVpoKR-qjJhuipPHDu2hOC8yUobnzjHU-vzmX22BaM-F6aJdu9dkm1OA7E05dXhPElbNgTNOyzJH0RBWLrqG7aU2KG8ewe2HVsq5APYnp6EwdeGKdXWVNI5On_mH_tu7kg31Myb0ZIrl-l9uFvnc7b8xrLsl13p6CEk_XjaYJTLYV3xYXz9G9Xjfw74ETzotFYMWpg9hi2RP4G9sKW9Xh7gZJ3FVR7gHoZrQuzlU_gRrrMTkOUJfil4XVa0yGKRolRBcUxfgyO2yAr8dNXYBNT4lFHAe36OQXZeLGbVxRU2MQ4YsgUVgclm1yLBUzX4EIQTlO_A90zCrnkJrXSZ-I5jQcnNDR81UuW3rHwG06OPk9Gx2hWCUGOprVWqa1qWSBKu6UII19FjYQlfmtE6c7hjaczWEkNecOVmm8i_5SQe457jeb7ncV_IRWwHBnmRi11A4RixlZrS6IoNgqcf-xY39Jio9WJueApoPRiiuGNJp2IdWUTWknx41E5FJKcioqmIfAXerbrMW4qQ2xpjj7BICjJ5Z1guirqMPMr6lXJjKPC8BdzqaYZuShBrpgLuBhRXDYgjfPNOPrtouMLNtoKBAvs9xqJukSpv-8j9Fa7_PqQX_9T6Jdxrj-XpIOsVDKpFLV5Lva7ibzq5_QmrbkcB priority: 102 providerName: Unpaywall  | 
    
| Title | Performance and Robustness of the Monte Carlo Importance Sampling Algorithm Using Parallelized S-ADAPT for Basic and Complex Mechanistic Models | 
    
| URI | https://link.springer.com/article/10.1208/s12248-011-9258-9 https://www.ncbi.nlm.nih.gov/pubmed/21374103 https://www.proquest.com/docview/864784502 https://pubmed.ncbi.nlm.nih.gov/PMC3085700 https://link.springer.com/content/pdf/10.1208/s12248-011-9258-9.pdf  | 
    
| UnpaywallVersion | publishedVersion | 
    
| Volume | 13 | 
    
| hasFullText | 1 | 
    
| inHoldings | 1 | 
    
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVFSB databaseName: Free Full-Text Journals in Chemistry customDbUrl: eissn: 1550-7416 dateEnd: 20161231 omitProxy: true ssIdentifier: ssj0032311 issn: 1550-7416 databaseCode: HH5 dateStart: 19990101 isFulltext: true titleUrlDefault: http://abc-chemistry.org/ providerName: ABC ChemistRy – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1550-7416 dateEnd: 20161231 omitProxy: true ssIdentifier: ssj0032311 issn: 1550-7416 databaseCode: DIK dateStart: 20040101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1550-7416 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0032311 issn: 1550-7416 databaseCode: GX1 dateStart: 20040101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVLSH databaseName: SpringerLink Journals customDbUrl: mediaType: online eissn: 1550-7416 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0032311 issn: 1550-7416 databaseCode: AFBBN dateStart: 19990601 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1550-7416 dateEnd: 20161231 omitProxy: true ssIdentifier: ssj0032311 issn: 1550-7416 databaseCode: RPM dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVAVX databaseName: SpringerLINK - Czech Republic Consortium customDbUrl: eissn: 1550-7416 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0032311 issn: 1550-7416 databaseCode: AGYKE dateStart: 19990101 isFulltext: true titleUrlDefault: http://link.springer.com providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1550-7416 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0032311 issn: 1550-7416 databaseCode: U2A dateStart: 19990601 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1550-7416 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0032311 issn: 1550-7416 databaseCode: U2A dateStart: 19050626 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature  | 
    
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9RADB5BewAOiGcJj5UPqAfaiDwmr2MoLQW0VUR3pfYUzUxm25XSpNpkBcuf4C9j57Wsioq4TuaRxB6PPbY_M_Y2IneeJbnJpY0GyiyamUK7gSkz31NcaymbrLTxiX885V_OvLMuj7vqo917l2QjqRsEBCt8X5EPiAKvbDNyPNyld9m2R2heyMRTJ-7Fr4sKi925L_86bPMAuqFV3gyOHDykD9i9ZXEtVt9Fnv9xCB09Yg877RHiltyP2R1dPGG7SQs_vdqHyTqbqtqHXUjWwNSrp-xXss4SAFFk8K2Uy6omYQflDFAVhDGBVcGBWOQlfL5qdHPqfCoo8Ly4gDi_KBfz-vIKmlgDSMSCirHk8586g1Mz_hgnE8A14INA8jeLkMTJ9Q8Ya0oybnChgSqw5dUzNj06nBwcm11BBlOh1lSbgcu5zjJp2VrrwLeV5jpCc9YWvvS5JTwrc7AhwEMvw3_vZ6GQoR-GURjKSKMwec62irLQLxho31F85qLxoxxik0hFXDq2Iog7JZ3QYFZPpVR1aOVUNCNPyWrBydOWsCkSNiXCppHB3g1Drluojts6Q0_6FDcUeUlEoctllYaUfYv86xhsp-WEYTbHdlEBs1yDBRs8MnQgrO7NJ8X8ssHsdttKAgbb67kp7YRFddtL7g0M9-9Pevlfc79i99vrcbpQes226sVSv0H9qpYjth1_Ov96OKJTzhs1uwvbpidJfP4bWuYi3Q | 
    
| linkProvider | Springer Nature | 
    
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LU9RAEO7S5YAcfCvx2QeLgxDMYzaPY0RwEZZKSajC09RMMgtbhoTaJKXLn_AvO5PXumJhcU3mkUn39HRPd38N8M5X7jyDE51wUxooE3-iM2G7Ok-cYUyE4LzOShsfOaMT8uV0eNrmcRddtHvnkqwldY2AYHgfCuUDUoFXpu5bQ7lL78IKkfaJNYCV4PO3g91OANtSZTFbB-Y_Oy4fQdf0yuvhkb2PdA1Wq-ySzX-wNP3jGNp7AFG3gCb65Pt2VfLt-OovbMdbrvAh3G_VUgwaPnoEd0T2GDbCBtd6voXRIk2r2MINDBeI1_Mn8CtcpB8gyxL8mvOqKJUUxXyCUsfEsULBwh02S3Pcv6iVftX4mKmI9uwMg_Qsn03L8wusgxgwZDNV5SWdXokEj_XgUxBGKOfAj0zyVT2JEmWp-IljobKXa8BpVKXd0uIpnOztRjsjva30oMdSHSt11yZEJAk3TCGE65ixIMKXdrLJHO4Qgw2NxJIPXHmaJvJPOYnHuOd4nu953BdSSj2DQZZnYh1QOFZMJra0qmJL8Z8f-4RbZqyw82JueRoYHfFp3MKgq2ocKVXmkBycNmSgkgxUkYH6Grzvu1w2GCA3NcaOo6jcqcr9wjKRVwX1VFqv3BiWBs8bButHs0xbanaGrYG7xHp9AwUCvvwmm57XYOB2U6JAg82Op2grhYqbPnKz5-P_L-nFrcZ-C6ujaHxID_ePDl7CveYOXt1avYJBOavEa6nElfxNu2l_Az5dPm0 | 
    
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Zb9NAEF5BkTgeEFfBnPOA-kBr1cfGsR9NS9QCqSyaSH1b7drrNpJrR7GjNvwJ_jIzvkJUVMSrvYe9Mzs7szPzDWMfA3LnWYqbXNlooKRBakrtDk2VeIOYa61UnZU2PvGOpvzr2eCsrXNadtHunUuyyWkglKa82p8naYOGYPn7JfmDKAjLNgNngDv2LrvHCScBGXrqhJ0odlF5sVtX5l-7bR5GNzTMm4GSvbf0EXuwzOdydSWz7I8DafSEPW41SQgb0j9ld3T-jO1EDRT1ag8m68yqcg92IFqDVK-es1_ROmMAZJ7Aj0Ity4oEHxQpoFoIY1oSOJCLrIDjy1pPp8ankoLQ83MIs_NiMasuLqGOO4BILqgwSzb7qRM4NcPDMJoAzgGfJbJCPQlJn0xfw1hTwnGNEQ1UjS0rX7Dp6Mvk4MhsizOYMWpQlTl0OddJoixbaz307FhzHaBpa0tPedySAytx8MEQD8AE195LfKl8z_cD31eBRsGyzbbyItevGGjPiXnqoiEUO8QyQRxw5dgxwd3FyvENZnVUEnGLXE4FNDJBFgwOLhrCCiSsIMKKwGCf-i7zBrbjtsbQkV7g5iKPicx1sSyFT5m4yMuOwV42nNCP5tguKmOWa7DhBo_0DQi3e_NNPruo8bvdpqqAwXY7bhKt4Chv-8jdnuH-_Uuv_2vsD-x-dDgS349Pvr1hD5tbc7pnesu2qsVSv0O1q1Lv6631G0s5Jds | 
    
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEB6V9AAceJeal-aAeqB16vfjaAJVQUpl0UQqJ2vXXrdRXTuKbUH6J_jL7PiREIqKEFd71_Z6v9md2Zn5BuCtT-48jVuqxXVpoKR-qjJhuipPHDu2hOC8yUobnzjHU-vzmX22BaM-F6aJdu9dkm1OA7E05dXhPElbNgTNOyzJH0RBWLrqG7aU2KG8ewe2HVsq5APYnp6EwdeGKdXWVNI5On_mH_tu7kg31Myb0ZIrl-l9uFvnc7b8xrLsl13p6CEk_XjaYJTLYV3xYXz9G9Xjfw74ETzotFYMWpg9hi2RP4G9sKW9Xh7gZJ3FVR7gHoZrQuzlU_gRrrMTkOUJfil4XVa0yGKRolRBcUxfgyO2yAr8dNXYBNT4lFHAe36OQXZeLGbVxRU2MQ4YsgUVgclm1yLBUzX4EIQTlO_A90zCrnkJrXSZ-I5jQcnNDR81UuW3rHwG06OPk9Gx2hWCUGOprVWqa1qWSBKu6UII19FjYQlfmtE6c7hjaczWEkNecOVmm8i_5SQe457jeb7ncV_IRWwHBnmRi11A4RixlZrS6IoNgqcf-xY39Jio9WJueApoPRiiuGNJp2IdWUTWknx41E5FJKcioqmIfAXerbrMW4qQ2xpjj7BICjJ5Z1guirqMPMr6lXJjKPC8BdzqaYZuShBrpgLuBhRXDYgjfPNOPrtouMLNtoKBAvs9xqJukSpv-8j9Fa7_PqQX_9T6Jdxrj-XpIOsVDKpFLV5Lva7ibzq5_QmrbkcB | 
    
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Performance+and+Robustness+of+the+Monte+Carlo+Importance+Sampling+Algorithm+Using+Parallelized+S-ADAPT+for+Basic+and+Complex+Mechanistic+Models&rft.jtitle=The+AAPS+journal&rft.au=Bulitta%2C+Jurgen+B.&rft.au=Landersdorfer%2C+Cornelia+B.&rft.date=2011-06-01&rft.pub=Springer+US&rft.eissn=1550-7416&rft.volume=13&rft.issue=2&rft.spage=212&rft.epage=226&rft_id=info:doi/10.1208%2Fs12248-011-9258-9&rft_id=info%3Apmid%2F21374103&rft.externalDocID=PMC3085700 | 
    
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1550-7416&client=summon | 
    
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1550-7416&client=summon | 
    
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1550-7416&client=summon |